Small intestinal vasoactive intestinal peptide producing tumor

Summary

Small intestinal vasoactive intestinal peptide producing tumor (MONDO:0003621) is a cancer. A subtype of small intestine neuroendocrine tumor, well differentiated, low or intermediate grade — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	small intestinal vasoactive intestinal peptide producing tumor
Mondo ID	MONDO:0003621
DOID	DOID:5740
NCIT	C27455
UMLS	C1336009
MedGen	277655
GARD	0023590
Is cancer (heuristic)	yes

Also known as: small intestinal vasoactive intestinal peptide producing tumor · small intestinal VIP-producing NET · small intestinal VIP-producing neuroendocrine tumor · small intestinal VIP-producing neuroendocrine tumour · small intestinal VIPoma

Disease family

This is a subtype of small intestine neuroendocrine tumor, well differentiated, low or intermediate grade. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system neuroendocrine neoplasm › digestive system neuroendocrine tumor, grade 1/2 › small intestine neuroendocrine tumor, well differentiated, low or intermediate grade › small intestinal vasoactive intestinal peptide producing tumor

Related subtypes (5): small intestinal neuroendocrine tumor G1, small intestinal L-cell glucagon-like peptide producing tumor, duodenal neuroendocrine tumor, well differentiated, low or intermediate grade, jejunal neuroendocrine tumor, well differentiated, low or intermediate grade, ileal neuroendocrine tumor, well differentiated, low or intermediate grade

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.